Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study
Sobrino Moreiras, Tomas; Rodríguez Yáñez, Manuel; Campos Pérez, Francisco; Iglesias Rey, Ramón; Millán, Mónica; de la Ossa, Natalia Pérez; Dávalos, Antonio; Delgado-Mederos, Raquel; Martínez-Domeño, Alejandro; Martí-Fábregas, Joan; Castellanos Rodrigo, María del Mar; Serena, Joaquín; Lago, Aida; Díez-Tejedor, Exuperio; Castillo Sánchez, José
Identificadores
Identificadores
Visualización ou descarga de ficheiros
Visualización ou descarga de ficheiros
Data de publicación
2020Título da revista
TRANSLATIONAL STROKE RESEARCH
Tipo de contido
Journal Article
DeCS
pronóstico | anciano | quimiocina CXCL12 | estudios prospectivos | mediana edad | humanos | péptidos y proteínas de señalización intercelularMeSH
Middle Aged | Humans | Prospective Studies | Intercellular Signaling Peptides and Proteins | Aged | Chemokine CXCL12 | PrognosisResumo
The main objective of this research work was to study the association of serum levels of growth factors (GF) and SDF-1alpha with the functional outcome and reduction of lesion volume in ischemic stroke patients. In this multicenter study, 552 patients with non-lacunar stroke (male, 62.1%; mean age, 68.2 +/- 11.4) were included within 24 h from symptom onset. The main outcome variable was good functional outcome (modified Rankin Scale [mRS] </= 2) at 12 months. Secondary outcome variable was infarct volume (in mL) after 6 +/- 3 months. Serum levels of VEGF, Ang-1, G-CSF, BDNF, and SDF-1alpha were measured by ELISA at admission, 7 +/- 1 days, at 3 +/- 1 months, and 12 +/- 3 months. Except for BDNF, all GF and SDF-1alpha serum levels showed a peak value at day 7 and remained elevated during the first 3 months (all p < 0.01). High serum levels at day 7 of VEGF (OR, 19.3), Ang-1 (OR, 14.7), G-CSF (OR, 9.6), and SDF-1alpha (OR, 28.5) were independently associated with good outcome at 12 months (all p < 0.0001). On the other hand, serum levels of VEGF (B, - 21.4), G-CSF (B, - 14.0), Ang-1 (B, - 13.3), and SDF-1alpha (B, - 44.6) measured at day 7 were independently associated with lesion volume at 6 months (p < 0.01). In summary, high serum levels of VEGF, Ang-1, G-CSF, and SDF-1alpha at day 7 and 3 months after ischemic stroke are associated with good functional outcome and smaller residual lesion at 1 year of follow-up.